Statement of Organization, Functions, and Delegations of Authority, 51069-51070 [05-17072]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 166 / Monday, August 29, 2005 / Notices
a recipient address for the shipment of
KI;
• Specify the decision-making criteria
for KI administration;
• Specify the criteria for issuing KI to
the public (location, special need);
• Specify the method for making KI
available to the public; pre-distribution
or stockpiling;
• Specify the method for ensuring the
supply of KI is sufficient for the targeted
population, including the estimated
transient/seasonal population that may
be advised to take KI;
• If pre-distributing KI, specify the
procedure for the public or special
population groups to obtain KI;
• Specify the procedure for storing,
monitoring, safeguarding, dispensing (to
include, if applicable, tracking who
received the drug, when, in what
quantity, and maintenance of waivers
from liability), and disposing of KI
stocks;
• Identify the method for alerting and
notifying the general public of the
recommendation to take KI;
• Specify how the plan is integrated
into existing emergency response plans;
and
• Specify quantities of KI (tablets and
pediatric liquid oral formulation) that
will be requested.
C. Local Governments
KI requests from local governments
must certify that:
• The State in which the local
government is located does not have a
DHS-approved KI distribution plan that
includes KI as a protective measure for
populations, or a DHS approved plan
that does not address populations
located beyond 10 miles from the
commercial nuclear power plant;
• The local government has
petitioned the State in which it is
located to modify the State plan to
address populations within 20 miles of
a commercial nuclear power plant, and
60 days have elapsed without the State
modifying the plan to accommodate the
request;
• The local government KI plans have
been approved by the State and certified
to be ‘not inconsistent’ with the State
emergency plan; and
• The local government has reached
an agreement with the State that the
State will serve as the single point of
contact for receipt of KI shipments from
the stockpile and will then redistribute
the KI to the approved governments.
Funding and Resource Requirements
State, local, and tribal governments
are responsible for obtaining the
funding and resources necessary to
request and implement the KI program
VerDate Aug<18>2005
15:17 Aug 26, 2005
Jkt 205001
within their respective jurisdictions,
should they decide to request KI. Only
the provision of KI tablets/liquid will be
funded through HHS.
Dated: August 24, 2005.
Robert G. Claypool,
Deputy Assistant Secretary, Office of Public
Health Emergency Preparedness, Department
of Health and Human Services.
References
A. NUREG–0654/DHS–REP–1, Criteria for
Preparation and Evaluation of
Radiological Emergency Response Plans
and Preparedness in Support of Nuclear
Power Plants, March 1987.
B. NUREG–0396/EPA 520/1–78–016,
Planning Basis for the Development of
State and Local Government Radiological
Emergency Response Plans in Support of
Light Water Nuclear Power Plants,
December 1978.
C. National Academy of Sciences (NAS)
Study, Distribution and Administration
of Potassium Iodide in the Event of a
Nuclear Incident, January 2004.
D. Federal Emergency Management Agency,
Notice of revised Federal policy, Federal
Policy on Use of Potassium Iodide (KI),
67 FR 1355, January 10, 2002.
E. Nuclear Regulatory Commission, Final
rule, Consideration of Potassium Iodide
in Emergency Plans, 66 FR, 5427,
January 19, 2001.
F. World Health Organization, Guidelines for
Iodine Prophylaxis Following Nuclear
Accidents, 1999. https://www.who.int/
environmentalinformation/
Information_resources/documents/
Iodine/guide.pdf.
G. National Council on Radiation Protection
and Measures (NCRP) Protection of the
Thyroid Gland in the Event of Releases
of Radioiodine. NCRP Report No. 55,
August 1, 1977.
H. Food and Drug Administration
(Department of Health and Human
Services), Potassium Iodide as a ThyroidBlocking Agent in Radiation
Emergencies; 66 FR 64046, December 11,
2001. https://www.fda.gov/cder/guidance/
4825fnl.htm.
I. Report of the President’s Commission on
the Accident at Three Mile Island.
J. Federal Emergency Management Agency,
Federal Policy on Distribution of
Potassium Iodide Around Nuclear Power
Sites for Use as a Thyroidal Blocking
Agency, 50 FR, 30258, July 24, 1985.
K. Nauman, J., and Wolff, J., Iodide
Prophylaxis in Poland After the
Chernobyl Reactor Accident: Benefits
and Risks, American Journal of
Medicine, Vol. 94, p. 524, May 1993.
L. International Atomic Energy Agency,
International Basic Safety Standards for
Protection Against Ionizing Radiation
and for Safety of Radiation Sources.
Safety Series No. 115, 1996.
M. Food and Drug Administration
(Department of Health and Human
Services) Guidance for Industry KI in
Radiation Emergencies—Questions and
Answers, https://www.fda.gov/cder/
guidance/5386fnl.htm.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
51069
N. Food and Drug Administration
(Department of Health and Human
Services) Frequently Asked Questions on
Potassium Iodide (KI). https://
www.fda.gov/cder/drugprepare/
KI_Q&A.htm.
O. Food and Drug Administration
(Department of Health and Human
Services) Guidance for Federal Agencies
and State and Local Governments:
Potassium Iodide Tablets: Shelf Life
Extension. https://www.fda.gov/cder/
guidance/5666fnl.pdf.
P. National Council on Radiation Protection
and Measures (NCRP) Report 138,
Management of Terrorist Events
Involving Radioactive Materials.
[FR Doc. 05–17223 Filed 8–25–05; 2:41 pm]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 46527–46530,
dated August 10, 2005) is amended to
reflect the establishment of the Office of
Chief of Public Health Practice within
the Office of the Director, Centers for
Disease Control and Prevention.
After the mission statement for the
Office of Workforce and Career
Development (CAL), insert the
following:
Office of Chief of Public Health
Practice (CAR). The Office of Chief of
Public Health Practice (OCPHP) serves
as the advocate, guardian, promoter, and
conscience of public health practice
throughout CDC and in the larger public
health community; ensures coordination
and synergy of CDC’s scientific and
practice activities; and promotes and
protects the public’s health through
science-based, practice-relevant
standards, policies, and legal tools.
Activities in support of the mission are
carried out through programs and
offices focused on public health law,
public health system standards, agency
accreditation, and surveillance for
emerging issues in public health
practice. To carry out its mission,
OCPHP: (1) Develops the legal
preparedness of CDC programs and the
public health system to address
terrorism and other national public
E:\FR\FM\29AUN1.SGM
29AUN1
51070
Federal Register / Vol. 70, No. 166 / Monday, August 29, 2005 / Notices
health priorities; (2) improves the
understanding and use of law as a
public health tool by CDC programs and
extramural partners; (3) establishes
robust partnerships among CDC
programs, public health practitioners
and key sectors, including elected
officials, the legal community, and law
enforcement and emergency response
organizations; (4) establishes a
functional area focused specifically on
standards and improvement in practice
among state and local public health
systems; (5) advances the development
and implementation of a national
agency accreditation system; (6) relates
relevant research and policy analysis to
public health practice; (7) monitors and
anticipates public health practice trends
and issues; and (8) coordinates and
addresses cross-cutting issues related to
public health practice within CDC.
Dated: August 10, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 05–17072 Filed 8–26–05; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 46527–46530,
dated August 10, 2005) is amended to
reflect the establishment of the
Coordinating Center for Infectious
Diseases at the Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the mission statement for the
Centers for Disease Control and
Prevention (C), insert the following:
Coordinating Center for Infectious
Diseases (CV). The mission of the
Coordinating Center for Infectious
Diseases (CCID) is to protect health and
enhance the potential for full, satisfying
and productive living across the
lifespan of all people in all communities
related to infectious diseases.
To carry out its mission, CCID: (1)
Fosters collaborations, partnerships,
VerDate Aug<18>2005
15:17 Aug 26, 2005
Jkt 205001
integration, and resource leveraging to
increase CDC’s health impact and
achieve population health goals; (2)
helps investigate and diagnose
infectious diseases of public health
significance; (3) coordinates applied and
operational research to define, prevent,
and control infectious diseases; (4)
assists in providing consultation and
training to help state and local health
departments plan, develop, implement
and improve immunization programs;
(5) coordinates research and operational
programs to prevent and control
vaccine-preventable diseases; (6) assists
in providing technical assistance to
states, localities, and other nations to
investigate and diagnose sexually
transmitted diseases (STDs),
tuberculosis (TB), human
immunodeficiency virus (HIV)
infections, and retroviruses; and
coordinates applied and operational
research on the spread, diagnosis,
prevention and control of HIV, other
STDs, TB, and non-TB mycobacteria,
and non-HIV retroviruses.
Office of the Director (CVA). Manages,
coordinates, and evaluates the activities
of the CCID; (2) communicates
overarching goals and objectives and
provides leadership, scientific oversight
and guidance in program planning and
development; (3) coordinates assistance
provided by CCID to other CDC
components, other federal, state, and
local agencies, the private sector and
other nations; (4) provides and
coordinates resource management
support services for CCID, (e.g., for
grants, cooperative agreements, and
other assistance mechanisms); (5)
coordinates workforce development
activities within CCID and coordinates
the recruitment, assignment, technical
supervision, and career development of
staff, with emphasis on goals for equal
employment opportunity and diversity
where appropriate; (6) assists in the
development and implementation of a
comprehensive communication program
for CCID, assuring that the center’s
health information is accurately and
appropriately represented to a diversity
of constituencies and ensuring
integration with CDC-wide
communications activities; (7) provides
liaison with other governmental
agencies, international organizations,
and outside groups representing the
infectious disease activities of CDC; and,
(8) collaborates as appropriate with
other coordinating centers, offices, and
institutes of CDC, other public health
service agencies, and other federal
agencies.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Dated: August 10, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 05–17074 Filed 8–26–05; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 70 FR 46527–46530,
dated August 10, 2005) is amended to
reflect the establishment of the
Coordinating Center for Health
Information and Service at the Centers
for Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the mission statement for the
Centers for Disease Control and
Prevention (C), delete the title
Coordinating Center for Health
Information and Service (CP) and insert
the following:
Coordinating Center for Health
Information and Service (CP). The
mission of the Coordinating Center for
Health Information and Service (CCHIS)
is to assure that CDC provides highquality information and programs in the
most effective ways to help people,
families, and communities protect their
health and safety. Through continuous
consumer input, prevention research,
and public health information
technology, we identify and evaluate
health needs and interests, translate
science into actions to meet those needs,
and engage the public in the excitement
of discovery and the progress being
made to improve the health of the
nation.
In carrying out its mission, the CCHIS
(1) fosters collaborations, partnerships,
integration, and resource leveraging to
increase CDC’s health impact and
achieve population health goals; (2)
disseminates and evaluates CDC
programs and products; (3) manages
programs, messages to the public, and
policies in innovative ways; (4)
monitors, analyzes, and disseminates
high quality, timely health information
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 70, Number 166 (Monday, August 29, 2005)]
[Notices]
[Pages 51069-51070]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-17072]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 70 FR 46527-46530, dated August 10, 2005) is
amended to reflect the establishment of the Office of Chief of Public
Health Practice within the Office of the Director, Centers for Disease
Control and Prevention.
After the mission statement for the Office of Workforce and Career
Development (CAL), insert the following:
Office of Chief of Public Health Practice (CAR). The Office of
Chief of Public Health Practice (OCPHP) serves as the advocate,
guardian, promoter, and conscience of public health practice throughout
CDC and in the larger public health community; ensures coordination and
synergy of CDC's scientific and practice activities; and promotes and
protects the public's health through science-based, practice-relevant
standards, policies, and legal tools. Activities in support of the
mission are carried out through programs and offices focused on public
health law, public health system standards, agency accreditation, and
surveillance for emerging issues in public health practice. To carry
out its mission, OCPHP: (1) Develops the legal preparedness of CDC
programs and the public health system to address terrorism and other
national public
[[Page 51070]]
health priorities; (2) improves the understanding and use of law as a
public health tool by CDC programs and extramural partners; (3)
establishes robust partnerships among CDC programs, public health
practitioners and key sectors, including elected officials, the legal
community, and law enforcement and emergency response organizations;
(4) establishes a functional area focused specifically on standards and
improvement in practice among state and local public health systems;
(5) advances the development and implementation of a national agency
accreditation system; (6) relates relevant research and policy analysis
to public health practice; (7) monitors and anticipates public health
practice trends and issues; and (8) coordinates and addresses cross-
cutting issues related to public health practice within CDC.
Dated: August 10, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 05-17072 Filed 8-26-05; 8:45 am]
BILLING CODE 4160-18-M
